Long-term risk of recurrent atrial fibrillation as documented by an implantable monitoring device
Implications for optimal patient care
Carsten W. Israel, MD*,
Gerian Grönefeld, MD*,
Joachim R. Ehrlich, MD*,
Yi-Gang Li, MD* and
Stefan H. Hohnloser, MD, FACC, FESC*,*
* J. W. Goethe University Hospital, Department of Medicine, Division of Cardiology, Frankfurt, Germany
View larger version (6K):
[in a new window]
|
Figure 1 Cumulative incidence of asymptomatic atrial fibrillation recurrence >48 h not detected by serial electrocardiographic recordings during follow-up (FU) visits.
|
|
View larger version (9K):
[in a new window]
|
Figure 2 Cumulative incidence of detection of any atrial fibrillation recurrence by electrocardiographic recording during follow-up (FU) (solid line) versus information from the implanted device (dashed line). n = number of patients at risk.
|
|
View larger version (10K):
[in a new window]
|
Figure 3 Prevalence of atrial fibrillation (AF) recurrences of various durations detected during follow-up.
|
|
|
